Pharmaceutical formulations with P-glycoprotein inhibitory effect as promising approaches for enhancing oral drug absorption and bioavailability
P-glycoprotein (P-gp) is crucial in the active transport of various substrates with diverse
structures out of cells, resulting in poor intestinal permeation and limited bioavailability …
structures out of cells, resulting in poor intestinal permeation and limited bioavailability …
Intestinal drug transporters: an overview
The importance of drug transporters as one of the determinants of pharmacokinetics has
become increasingly evident [1]. While much research has been conducted focusing the role …
become increasingly evident [1]. While much research has been conducted focusing the role …
The intestinal absorption of folates
M Visentin, N Diop-Bove, R Zhao… - Annual review of …, 2014 - annualreviews.org
The properties of intestinal folate absorption were documented decades ago. However, it
was only recently that the proton-coupled folate transporter (PCFT) was identified and its …
was only recently that the proton-coupled folate transporter (PCFT) was identified and its …
Significance of the vitamin D receptor on crosstalk with nuclear receptors and regulation of enzymes and transporters
The vitamin D receptor (VDR), in addition to other nuclear receptors, the pregnane X
receptor (PXR) and constitutive androstane receptor (CAR), is involved in the regulation of …
receptor (PXR) and constitutive androstane receptor (CAR), is involved in the regulation of …
Intestinal CYP3A4 protects against lithocholic acid-induced hepatotoxicity in intestine-specific VDR-deficient mice [S]
J Cheng, ZZ Fang, JH Kim, KW Krausz, N Tanaka… - Journal of lipid …, 2014 - ASBMB
Vitamin D receptor (VDR) mediates vitamin D signaling involved in bone metabolism,
cellular growth and differentiation, cardiovascular function, and bile acid regulation. Mice …
cellular growth and differentiation, cardiovascular function, and bile acid regulation. Mice …
[HTML][HTML] Involvement of CYP3A4 and MDR1 in altered metabolism and transport of indinavir in 1, 25 (OH) 2D3-treated Caco-2 cells
SJ Lee, SA Joo, H Kim, Y Lee, SJ Chung… - European Journal of …, 2023 - Elsevier
Altered drug concentrations may induce unexpected toxicity or treatment failure; thus,
understanding the factors that alter the pharmacokinetic profiles of drugs is crucial for …
understanding the factors that alter the pharmacokinetic profiles of drugs is crucial for …
Effects of 1α,25-dihydroxyvitamin D3 on the pharmacokinetics and biodistribution of ergothioneine, an endogenous organic cation/carnitine transporter 1 substrate, in …
DK Vo, TTL Nguyen, HJ Maeng - Journal of Pharmaceutical Investigation, 2022 - Springer
Purpose This study aimed to investigate the effects of 1α, 25-dihydroxyvitamin D3 (1, 25
(OH) 2D3) on the expression levels of organic cation/carnitine transporter 1 (OCTN1) as well …
(OH) 2D3) on the expression levels of organic cation/carnitine transporter 1 (OCTN1) as well …
The SLCO1A2 gene, encoding human organic anion-transporting polypeptide 1A2, is transactivated by the vitamin D receptor
JJ Eloranta, C Hiller, M Jüttner, GA Kullak-Ublick - Molecular Pharmacology, 2012 - ASPET
Organic anion-transporting polypeptide 1A2 (OATP1A2)(gene symbol, SLCO1A2) mediates
cellular uptake of a wide range of endogenous substrates, as well as drugs and xenobiotics …
cellular uptake of a wide range of endogenous substrates, as well as drugs and xenobiotics …
Differential Effects of 1α,25-Dihydroxyvitamin D3 on the Expressions and Functions of Hepatic CYP and UGT Enzymes and Its Pharmacokinetic Consequences In …
The compound 1α, 25-Dihydroxyvitamin D3 (1, 25 (OH) 2D3) is the active form of vitamin D3
and a representative ligand of the vitamin D receptor (VDR). Previous studies have …
and a representative ligand of the vitamin D receptor (VDR). Previous studies have …
Effects of 1α,25-Dihydroxyvitamin D3 on the Pharmacokinetics of Procainamide and Its Metabolite N-Acetylprocainamide, Organic Cation Transporter Substrates, in …
In this study, possible changes in the expression of rat organic cationic transporters (rOCTs)
and rat multidrug and toxin extrusion proteins (rMATEs) following treatment with 1α, 25 …
and rat multidrug and toxin extrusion proteins (rMATEs) following treatment with 1α, 25 …